Endocannabinoid
Resource Centre
TOP ARTICLES
Early Lab Study: Hemp Shows Therapeutic Potential for Reducing Ovarian Cancer Risk
Could non-psychoactive hemp be a viable use to reduce ovarian cancer risk? As we learn more about the bioactives in hemp, the possibility becomes ever real. At the 2018 annual Experimental Biology meeting in San Diego, graduate students, Sara Biela and Chase Turner, presented the first study to examine hemp and
Beyond CBD: Exploring the Endocannabinoid System in Health and Disease, with Carl Germano PhD
Eureka! We’ve been on the search and finally found a refreshingly honest interview on the subject of the endocannabinoid system and the use of cannabidiol in clinical practice. Not surprisingly, it came from Carl Germano, PhD, RD, CNS, CDN. Germano has been in private practice in integrative and nutritional therapiesRead
Interview with Jeffrey Chen, MD and Raphael Mechoulan, PhD on Endocannabinoids
This video, Jeffrey Chen, MD, the Director of the UCLA Cannabis Research Initiative, is the best explanation of the mechanisms and action potential of endocannabinoids in the human body. This is followed by and interview with Raphael Mechoulan, PhD, professor of Medicinal Chemistry at the Hebrew University of Jerusalem. Mechoulan
CBD Myth-Busting Study: High Doses of Cannabidiol Do Not Cause THC-Like Effects in Humans
Have you been hesitant to prescribe cannabidiol (CBD) because of concerns about gastric acids converting the CBD into psychoactive tetrahydrocannabinol (THC)? In 2016, a study by Merrick et al. suggested that when CBD is exposed to an acidic environment, it degrades to Δ9-tetrahydrocannabinol and other psychoactive cannabinoids. The following is
Cannabidiol Offers Inflammatory Properties for Contact Dermatitis
This study is the first demonstration of the anti-inflammatory properties of Cannabidiol in an experimental model for allergic contact dermatitis (ACD). Published in the J. Pharmacology and Experimental Therapeutics, March 2018. Abstract / Phytocannabinoids modulate inflammatory responses by regulating the production of cytokines in several experimental models of inflammation. Cannabinoid type-2
Cannabinoid Receptors and the Endocannabinoid System: What Is it and What Does it Do?
The endocannabinoid system consists of endogenous cannabinoids (endocannabinoids), cannabinoid receptors and the synthetic and degrading enzymes responsible for synthesis and degradation of endocannabinoids. Endocannabinoids are so named because they were first identified as activating the same receptors as cannabinoids, the primary psychoactive components of cannabis. Published in Journal of Neuroendocrinology 20
CBD for Drug and Alcohol Recovery? Preclinical Study Shows Cannabidiol (CBD) May Be An Effective Solution
Have you thought of prescribing CBD for drug and alcohol recovery? There is new evidence that the non-psychoactive and non-addictive ingredient, cannabidiol (CBD), could help prevent relapses for recovering drug addicts and alcoholics. This preclinical study’s findings provide further evidence about the possible medical benefits of non-psychoactive cannabinoids, and how
